Literature DB >> 14623837

Utility of blood cultures in the management of adults with community acquired pneumonia discharged from the emergency department.

S G Campbell1, T J Marrie, R Anstey, S Ackroyd-Stolarz, G Dickinson.   

Abstract

STUDY
OBJECTIVE: To assess the clinical value of blood cultures (BCs) in the management of adult patients discharged from the emergency department (ED) with a diagnosis of community acquired pneumonia (CAP).
METHODS: The courses of antibiotic regimens and outcomes of patients with positive BC results were examined to assess their influence on BCs.
RESULTS: BCs were obtained from 289 outpatients. Six clinically significant organisms were identified (a yield of 2.1%). Outpatients with CAP who had blood cultures performed had a 0.69% (2 of 289) chance of having a change of treatment directed by the results of the culture.
CONCLUSION: BCs have little utility in the ambulatory management of CAP.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14623837      PMCID: PMC1726243          DOI: 10.1136/emj.20.6.521

Source DB:  PubMed          Journal:  Emerg Med J        ISSN: 1472-0205            Impact factor:   2.740


  17 in total

1.  Nonvalue of the initial microbiological studies in the management of nonsevere community-acquired pneumonia.

Authors:  R Theerthakarai; W El-Halees; M Ismail; R A Solis; M A Khan
Journal:  Chest       Date:  2001-01       Impact factor: 9.410

2.  Initial microbiologic studies did not affect outcome in adults hospitalized with community-acquired pneumonia.

Authors:  S Sanyal; P R Smith; A C Saha; S Gupta; L Berkowitz; P Homel
Journal:  Am J Respir Crit Care Med       Date:  1999-07       Impact factor: 21.405

3.  The influence of the severity of community-acquired pneumonia on the usefulness of blood cultures.

Authors:  G W Waterer; R G Wunderink
Journal:  Respir Med       Date:  2001-01       Impact factor: 3.415

4.  The value of routine microbial investigation in community-acquired pneumonia.

Authors:  M A Woodhead; J Arrowsmith; R Chamberlain-Webber; S Wooding; I Williams
Journal:  Respir Med       Date:  1991-07       Impact factor: 3.415

5.  Contaminant blood cultures and resource utilization. The true consequences of false-positive results.

Authors:  D W Bates; L Goldman; T H Lee
Journal:  JAMA       Date:  1991-01-16       Impact factor: 56.272

6.  A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL Study Investigators. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin.

Authors:  T J Marrie; C Y Lau; S L Wheeler; C J Wong; M K Vandervoort; B G Feagan
Journal:  JAMA       Date:  2000-02-09       Impact factor: 56.272

7.  Community-acquired pneumonia. Importance of initial noninvasive bacteriologic and radiographic investigations.

Authors:  M Lévy; F Dromer; N Brion; F Leturdu; C Carbon
Journal:  Chest       Date:  1988-01       Impact factor: 9.410

8.  Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. American Thoracic Society. Medical Section of the American Lung Association.

Authors:  M S Niederman; J B Bass; G D Campbell; A M Fein; R F Grossman; L A Mandell; T J Marrie; G A Sarosi; A Torres; V L Yu
Journal:  Am Rev Respir Dis       Date:  1993-11

9.  Utility of blood cultures in pediatric patients found to have pneumonia in the emergency department.

Authors:  R W Hickey; M J Bowman; G A Smith
Journal:  Ann Emerg Med       Date:  1996-06       Impact factor: 5.721

10.  Clinical utility of blood cultures in adult patients with community-acquired pneumonia without defined underlying risks.

Authors:  N P Chalasani; M A Valdecanas; A K Gopal; J E McGowan; R L Jurado
Journal:  Chest       Date:  1995-10       Impact factor: 9.410

View more
  12 in total

Review 1.  Updated review of blood culture contamination.

Authors:  Keri K Hall; Jason A Lyman
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

2.  Blood cultures in ambulatory outpatients.

Authors:  Kevin B Laupland; Deirdre L Church; Daniel B Gregson
Journal:  BMC Infect Dis       Date:  2005-05-17       Impact factor: 3.090

3.  Utility of Blood Cultures in Pneumonia.

Authors:  David Zhang; Danny Yang; Anil N Makam
Journal:  Am J Med       Date:  2019-04-12       Impact factor: 4.965

4.  Factors associated with positive blood cultures in outpatients with suspected bacteremia.

Authors:  K Wildi; S Tschudin-Sutter; S Dell-Kuster; R Frei; H C Bucher; R Nüesch
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-20       Impact factor: 3.267

Review 5.  [Assessment, triage, and follow-up of a patient with: acute CAP COPD].

Authors:  K Faure
Journal:  Med Mal Infect       Date:  2006-11-07       Impact factor: 2.152

Review 6.  [Contribution of microbiological investigations to the diagnosis of lower respiratory tract infections].

Authors:  O Leroy
Journal:  Med Mal Infect       Date:  2006-11-13       Impact factor: 2.152

Review 7.  Urinary Antigen Testing for Respiratory Infections: Current Perspectives on Utility and Limitations.

Authors:  Priscilla Kim; Abhishek Deshpande; Michael B Rothberg
Journal:  Infect Drug Resist       Date:  2022-04-27       Impact factor: 4.177

8.  Safety and feasibility of antibiotic de-escalation in bacteremic pneumonia.

Authors:  Faisal A Khasawneh; Adnanul Karim; Tashfeen Mahmood; Subhan Ahmed; Sayyed F Jaffri; Mansoor Mehmood
Journal:  Infect Drug Resist       Date:  2014-06-27       Impact factor: 4.003

9.  Improved diagnosis of the etiology of community-acquired pneumonia with real-time polymerase chain reaction.

Authors:  Kate E Templeton; Sitha A Scheltinga; Willian C J F M van den Eeden; A Willy Graffelman; Peterhans J van den Broek; Eric C J Claas
Journal:  Clin Infect Dis       Date:  2005-06-22       Impact factor: 9.079

10.  Should Blood Cultures be Performed in Terminally Ill Cancer Patients?

Authors:  Nobuhiro Asai; Masahiro Aoshima; Yoshihiro Ohkuni; Yoshihito Otsuka; Norihiro Kaneko
Journal:  Indian J Palliat Care       Date:  2012-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.